speb/financial-data huggingface dataset:
BM8.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
BM8.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
BM8.AX cash_flow (annual, 2021-06-30) — Taxes Refund Paid Direct: 38515.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Assets: 5363847.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 5135037.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Debt: 46370.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 5135037.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 228810.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 1824437.00
BM8.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BM8.AX balance_sheet (annual, 2021-06-30) — Working Capital: 3310600.00
BM8.AX income_statement (annual, 2022-06-30) — +Operating Expense: 2038299.00
BM8.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 145642.00
BM8.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 57968163.00
BM8.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.07
BM8.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 3412277.00
BM8.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -406014.00
BM8.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -406014.00
BM8.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 41661.00
BM8.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 54370957.00
BM8.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 928865.00
BM8.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 928865.00
BM8.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 928865.00
BM8.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -20189.00
BM8.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -406014.00
BM8.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2057209.00
BM8.AX cash_flow (annual, 2022-06-30) — Changes In Cash: -2483412.00
BM8.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -2057208.00
BM8.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2154.00
BM8.AX balance_sheet (annual, 2022-06-30) — Common Stock: 54370957.00
BM8.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 9030734.00
BM8.AX balance_sheet (annual, 2022-06-30) — Current Assets: 1116226.00
BM8.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 29118.00
BM8.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 29118.00
BM8.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 174760.00
BM8.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 28965.00
BM8.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 28965.00
BM8.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 28965.00
BM8.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 57968163.00
BM8.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.07
BM8.AX income_statement (annual, 2022-06-30) — EBIT: 3859110.00
BM8.AX income_statement (annual, 2022-06-30) — EBITDA: 3888075.00
BM8.AX income_statement (annual, 2022-06-30) — Earnings From Equity Interest: -1114340.00
BM8.AX cash_flow (annual, 2022-06-30) — End Cash Position: 928865.00
BM8.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: -20189.00
BM8.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -2463223.00
BM8.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: -44043.00
BM8.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 384832.00
BM8.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 2216150.00
BM8.AX income_statement (annual, 2022-06-30) — Interest Expense: 4167.00
BM8.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 4167.00
BM8.AX income_statement (annual, 2022-06-30) — Interest Income: 2041.00
BM8.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 2041.00
BM8.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -4196.00
BM8.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 4196.00
BM8.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 2041.00
BM8.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 9030734.00
BM8.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -406014.00
BM8.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 5885661.00
BM8.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 12543.00
BM8.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 12543.00
BM8.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -20189.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Net Interest Income: -2126.00
BM8.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -20189.00
BM8.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -20189.00
BM8.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -2126.00
BM8.AX balance_sheet (annual, 2022-06-30) — Net PPE: 2216150.00
BM8.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 9030734.00
BM8.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 3888075.00
BM8.AX income_statement (annual, 2022-06-30) — Normalized Income: 3854943.00
BM8.AX income_statement (annual, 2022-06-30) — Operating Income: -2038299.00
BM8.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 57968163.00
BM8.AX cash_flow (annual, 2022-06-30) — Other Cash Paymentsfrom Operating Activities: -65374.00
BM8.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 2154.00
BM8.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 10000.00
BM8.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: -44043.00
BM8.AX income_statement (annual, 2022-06-30) — Other Income Expense: 5895368.00
BM8.AX balance_sheet (annual, 2022-06-30) — Other Investments: 5885661.00
BM8.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 7009708.00
BM8.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 1624502.00
BM8.AX balance_sheet (annual, 2022-06-30) — Other Properties: 2216150.00
BM8.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 32113.00
BM8.AX balance_sheet (annual, 2022-06-30) — Payables: 145642.00
BM8.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 145642.00
BM8.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -1991834.00
BM8.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 145248.00
BM8.AX income_statement (annual, 2022-06-30) — Pretax Income: 3854943.00
BM8.AX balance_sheet (annual, 2022-06-30) — Receivables: 32113.00
BM8.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 28965.00
BM8.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -20189.00
BM8.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -45296180.00
BM8.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 384832.00
BM8.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 384832.00
BM8.AX balance_sheet (annual, 2022-06-30) — Share Issued: 57968163.00
BM8.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 9030734.00
BM8.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 9030734.00
BM8.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
BM8.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
BM8.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Assets: 9218037.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 9030734.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Debt: 41661.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 9030734.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 187303.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 8101811.00
BM8.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 12543.00
BM8.AX balance_sheet (annual, 2022-06-30) — Working Capital: 941466.00
BM8.AX income_statement (annual, 2023-06-30) — +Operating Expense: 4089614.00
BM8.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 556426.00
BM8.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 66035947.00
BM8.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.07
BM8.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 928865.00
BM8.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -2334874.00
BM8.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -2186123.00
BM8.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 61273953.00
BM8.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 3200425.00
BM8.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 3200425.00
BM8.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 3200425.00
BM8.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 5938203.00
BM8.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -2334874.00
BM8.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1325115.00
BM8.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 2278214.00
BM8.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1412132.00
BM8.AX balance_sheet (annual, 2023-06-30) — Common Stock: 61273953.00
BM8.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 11617856.00
BM8.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 6628281.00
BM8.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -696335.00
BM8.AX balance_sheet (annual, 2023-06-30) — Current Assets: 3406935.00
BM8.AX balance_sheet (annual, 2023-06-30) — Current Debt: 6258.00
BM8.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 6258.00
BM8.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 1256981.00
BM8.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 27977.00
BM8.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 11158.00
BM8.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 11158.00
BM8.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 11158.00
BM8.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 66035947.00
BM8.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.07
BM8.AX income_statement (annual, 2023-06-30) — EBIT: -4531189.00
BM8.AX income_statement (annual, 2023-06-30) — EBITDA: -4520031.00
BM8.AX income_statement (annual, 2023-06-30) — Earnings From Equity Interest: -442845.00
BM8.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -6654.00
BM8.AX cash_flow (annual, 2023-06-30) — End Cash Position: 3200425.00
BM8.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 5938203.00
BM8.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -3659989.00
BM8.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 125948.00
BM8.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 616435.00
BM8.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 4039641.00
BM8.AX income_statement (annual, 2023-06-30) — Interest Expense: 2462.00
BM8.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 2462.00
BM8.AX income_statement (annual, 2023-06-30) — Interest Income: 421.00
BM8.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 421.00
BM8.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -2461.00
BM8.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 2461.00
BM8.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 421.00
BM8.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 11624114.00
BM8.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -2334874.00
BM8.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 5442816.00
BM8.AX balance_sheet (annual, 2023-06-30) — Investmentsin Associatesat Cost: 5442816.00
BM8.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 6628281.00
BM8.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 62570.00
BM8.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 62570.00
BM8.AX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -56313.00
BM8.AX balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 5442816.00
BM8.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 92324.00
BM8.AX balance_sheet (annual, 2023-06-30) — Minority Interest: 63555.00
BM8.AX income_statement (annual, 2023-06-30) — Minority Interests: 47786.00
BM8.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 5931946.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income: -4485865.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -4485865.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -4533651.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -4485865.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -4485865.00
BM8.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -4533651.00
BM8.AX cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -45269.00
BM8.AX income_statement (annual, 2023-06-30) — Net Interest Income: -2041.00
BM8.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 6257.00
BM8.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 6257.00
BM8.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -2041.00
BM8.AX balance_sheet (annual, 2023-06-30) — Net PPE: 4039641.00
BM8.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -103482.00
BM8.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 11617856.00
BM8.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -4520031.00
BM8.AX income_statement (annual, 2023-06-30) — Normalized Income: -4485865.00
BM8.AX income_statement (annual, 2023-06-30) — Operating Income: -4089614.00
BM8.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 76966493.00
BM8.AX cash_flow (annual, 2023-06-30) — Other Cash Paymentsfrom Operating Activities: -33647.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 6269.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 6258.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 125948.00
BM8.AX income_statement (annual, 2023-06-30) — Other Income Expense: -441996.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 49000.00
BM8.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 849.00
BM8.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 3462021.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Payable: 666320.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Properties: 3947317.00
BM8.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 97483.00
BM8.AX balance_sheet (annual, 2023-06-30) — Payables: 1222746.00
BM8.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 1222746.00
BM8.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1378485.00
BM8.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 102758.00
BM8.AX income_statement (annual, 2023-06-30) — Pretax Income: -4533651.00
BM8.AX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -45269.00
BM8.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -103482.00
BM8.AX balance_sheet (annual, 2023-06-30) — Receivables: 97483.00
BM8.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 11158.00
BM8.AX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -56313.00
BM8.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -696335.00
BM8.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -49782045.00
BM8.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 616435.00
BM8.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 616435.00
BM8.AX balance_sheet (annual, 2023-06-30) — Share Issued: 76966493.00
BM8.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 11617856.00
BM8.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 11617856.00
BM8.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
BM8.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
BM8.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
BM8.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: 89057.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Assets: 12938392.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 11617856.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Debt: 6258.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 11681411.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 1256981.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 9531457.00
BM8.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BM8.AX balance_sheet (annual, 2023-06-30) — Working Capital: 2149954.00
BM8.AX income_statement (annual, 2024-06-30) — +Operating Expense: 4249747.00
BM8.AX income_statement (annual, 2024-06-30) — +Total Revenue: 1000000.00
BM8.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 570601.00
BM8.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 89479723.00
BM8.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.04
BM8.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 3200425.00
BM8.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -5541194.00
BM8.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -5534322.00
BM8.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 66469054.00
BM8.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 1826367.00
BM8.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 1826367.00
BM8.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 1826367.00
BM8.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 6062158.00
BM8.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -4886194.00
BM8.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2537318.00
BM8.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -1361354.00
BM8.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -2978498.00
BM8.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 222691.00
BM8.AX balance_sheet (annual, 2024-06-30) — Common Stock: 66469054.00
BM8.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 13408899.00
BM8.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 6402921.00
BM8.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -334506.00
BM8.AX balance_sheet (annual, 2024-06-30) — Current Assets: 2098229.00
BM8.AX balance_sheet (annual, 2024-06-30) — Current Debt: 444202.00
BM8.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 444202.00
BM8.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 1219456.00
BM8.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 24052.00
BM8.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 24052.00
BM8.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 24052.00
BM8.AX income_statement (annual, 2024-06-30) — EBIT: -2650134.00
BM8.AX income_statement (annual, 2024-06-30) — EBITDA: -2626082.00
BM8.AX income_statement (annual, 2024-06-30) — Earnings From Equity Interest: -69245.00
BM8.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: -12704.00
BM8.AX cash_flow (annual, 2024-06-30) — End Cash Position: 1826367.00
BM8.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 6062158.00
BM8.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 68273.00
BM8.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -8078512.00
BM8.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 251152.00
BM8.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 1056982.00
BM8.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 8233185.00
BM8.AX income_statement (annual, 2024-06-30) — Gross Profit: 1000000.00
BM8.AX income_statement (annual, 2024-06-30) — Interest Expense: 1231.00
BM8.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 1231.00
BM8.AX income_statement (annual, 2024-06-30) — Interest Income: 53877.00
BM8.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 53877.00
BM8.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: 53803.00
BM8.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: -53803.00
BM8.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 13853101.00
BM8.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -4886194.00
BM8.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 5158030.00
BM8.AX balance_sheet (annual, 2024-06-30) — Investmentsin Associatesat Cost: 5158030.00
BM8.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 6402921.00
BM8.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -6257.00
BM8.AX balance_sheet (annual, 2024-06-30) — Long Term Equity Investment: 5158030.00
BM8.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 75166.00
BM8.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 6068415.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Net Interest Income: 52646.00
BM8.AX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 655000.00
BM8.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -6257.00
BM8.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -6257.00
BM8.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 52646.00
BM8.AX balance_sheet (annual, 2024-06-30) — Net PPE: 8233185.00
BM8.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -6872.00
BM8.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 13408899.00
BM8.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Liabilities: 917607.00
BM8.AX balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Liabilities: 917607.00
BM8.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -2626082.00
BM8.AX income_statement (annual, 2024-06-30) — Normalized Income: -3592816.00
BM8.AX income_statement (annual, 2024-06-30) — Operating Income: -4249747.00
BM8.AX income_statement (annual, 2024-06-30) — Operating Revenue: 1000000.00
BM8.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 93149140.00
BM8.AX cash_flow (annual, 2024-06-30) — Other Cash Paymentsfrom Operating Activities: -524821.00
BM8.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 222691.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 11606.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 444202.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 182879.00
BM8.AX income_statement (annual, 2024-06-30) — Other Income Expense: 1545736.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 56518.00
BM8.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 1614981.00
BM8.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 3709253.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Payable: 204653.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Properties: 8158019.00
BM8.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 189066.00
BM8.AX balance_sheet (annual, 2024-06-30) — Payables: 775254.00
BM8.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 775254.00
BM8.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -2453677.00
BM8.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 71190.00
BM8.AX income_statement (annual, 2024-06-30) — Pretax Income: -2651365.00
BM8.AX cash_flow (annual, 2024-06-30) — Purchase Of Investment: -325000.00
BM8.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -6872.00
BM8.AX balance_sheet (annual, 2024-06-30) — Receivables: 189066.00
BM8.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 24052.00
BM8.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -6257.00
BM8.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -334506.00
BM8.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -53311307.00
BM8.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 1056982.00
BM8.AX cash_flow (annual, 2024-06-30) — Sale Of Investment: 980000.00
BM8.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1056982.00
BM8.AX balance_sheet (annual, 2024-06-30) — Share Issued: 93149140.00
BM8.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 13408899.00
BM8.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 13408899.00
BM8.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
BM8.AX income_statement (annual, 2024-06-30) — Tax Provision: 941451.00
BM8.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.30
BM8.AX cash_flow (annual, 2024-06-30) — Taxes Refund Paid Direct: 164686.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Assets: 15545962.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 13408899.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Debt: 444202.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 13408899.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 2137063.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 13447733.00
BM8.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 917607.00
BM8.AX balance_sheet (annual, 2024-06-30) — Working Capital: 878773.00
BM8.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 106155381.00
BM8.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.03
BM8.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 106155381.00
BM8.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.03
BMA income_statement (annual, 2021-12-31) — +Total Revenue: 1127532034000.00
BMA balance_sheet (annual, 2021-12-31) — Accounts Receivable: 60095460000.00
BMA balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -34616413000.00
BMA balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 667736748000.00
BMA income_statement (annual, 2021-12-31) — Basic Average Shares: 63900000.00
BMA income_statement (annual, 2021-12-31) — Basic EPS: 673.10
BMA cash_flow (annual, 2021-12-31) — Beginning Cash Position: 2413599952000.00
BMA cash_flow (annual, 2021-12-31) — Capital Expenditure: -41809798000.00
BMA balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 2766394000.00
BMA balance_sheet (annual, 2021-12-31) — Capital Stock: 639413000.00
BMA balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 335692114000.00
BMA balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Federal Funds Sold: 396868471000.00
BMA balance_sheet (annual, 2021-12-31) — Cash Financial: 51862712000.00
BMA cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: -52643530000.00
BMA cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -42026069000.00
BMA cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: 271768205000.00
BMA cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -44393694000.00
BMA cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -36227516000.00
BMA cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -738686748000.00
BMA cash_flow (annual, 2021-12-31) — Change In Working Capital: -456145860000.00
BMA cash_flow (annual, 2021-12-31) — Changes In Cash: 177098606000.00
BMA balance_sheet (annual, 2021-12-31) — Common Stock: 639413000.00
BMA balance_sheet (annual, 2021-12-31) — Common Stock Equity: 466723603000.00
BMA cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
BMA balance_sheet (annual, 2021-12-31) — Construction In Progress: 3089819000.00
BMA cash_flow (annual, 2021-12-31) — Depreciation: 7125708000.00
BMA cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 43224593000.00
BMA income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 43224593000.00
BMA cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 43224593000.00
BMA income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 43224593000.00
BMA income_statement (annual, 2021-12-31) — Depreciation Income Statement: 43224593000.00
BMA balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 4933000.00
BMA income_statement (annual, 2021-12-31) — Diluted Average Shares: 63900000.00
BMA income_statement (annual, 2021-12-31) — Diluted EPS: 673.10
BMA income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: 138744986000.00
BMA balance_sheet (annual, 2021-12-31) — Dividends Payable: 51776837000.00
BMA cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: 164337260000.00
BMA balance_sheet (annual, 2021-12-31) — Employee Benefits: 824014000.00
BMA cash_flow (annual, 2021-12-31) — End Cash Position: 1880049576000.00
BMA cash_flow (annual, 2021-12-31) — Financing Cash Flow: -52643530000.00
BMA cash_flow (annual, 2021-12-31) — Free Cash Flow: 229958407000.00
BMA income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 101180879000.00
BMA balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: 366085407000.00
BMA income_statement (annual, 2021-12-31) — General And Administrative Expense: 345427999000.00
BMA balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 16370965000.00
BMA balance_sheet (annual, 2021-12-31) — Gross PPE: 137607897000.00
BMA cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 732306511000.00
BMA balance_sheet (annual, 2021-12-31) — Income Tax Payable: 20628821000.00
BMA income_statement (annual, 2021-12-31) — Insurance And Claims: 8510223000.00
BMA income_statement (annual, 2021-12-31) — Interest Expense: 574163457000.00
BMA income_statement (annual, 2021-12-31) — Interest Income: 1374260332000.00
BMA balance_sheet (annual, 2021-12-31) — Invested Capital: 554312315000.00
BMA cash_flow (annual, 2021-12-31) — Investing Cash Flow: -42026069000.00
BMA balance_sheet (annual, 2021-12-31) — Investments And Advances: 668690268000.00
BMA balance_sheet (annual, 2021-12-31) — Leases: 7353968000.00
BMA balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 2766394000.00
BMA balance_sheet (annual, 2021-12-31) — Long Term Debt: 87588712000.00
BMA balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 90355106000.00
BMA cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -47908004000.00
BMA balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 953520000.00
BMA balance_sheet (annual, 2021-12-31) — Long Term Provisions: 3221012000.00
BMA balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 31197304000.00
BMA balance_sheet (annual, 2021-12-31) — Minority Interest: 73788000.00
BMA income_statement (annual, 2021-12-31) — Minority Interests: -4534000.00
BMA cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -216271000.00
BMA cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
BMA cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: -104535187000.00
BMA income_statement (annual, 2021-12-31) — Net Income: 138744986000.00
BMA income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 138744986000.00
BMA income_statement (annual, 2021-12-31) — Net Income Continuous Operations: 138749520000.00
BMA income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: 138744986000.00
BMA income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: 138744986000.00
BMA cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 145943999000.00
BMA income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: 138749520000.00
BMA income_statement (annual, 2021-12-31) — Net Interest Income: 800096875000.00
BMA cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -47908004000.00
BMA cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -47908004000.00
BMA cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -4735526000.00
BMA balance_sheet (annual, 2021-12-31) — Net PPE: 102991484000.00
BMA cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -41809798000.00
BMA balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 450352638000.00
BMA balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 12169160000.00
BMA balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 12169160000.00
BMA balance_sheet (annual, 2021-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 824014000.00
BMA income_statement (annual, 2021-12-31) — Normalized Income: 520496133515.00
BMA income_statement (annual, 2021-12-31) — Occupancy And Equipment: 6461974000.00
BMA cash_flow (annual, 2021-12-31) — Operating Cash Flow: 271768205000.00
BMA cash_flow (annual, 2021-12-31) — Operating Gains Losses: -104535187000.00
BMA income_statement (annual, 2021-12-31) — Operating Revenue: 1127532034000.00
BMA balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 647052567.00
BMA cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -874986242000.00
BMA balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: 366085407000.00
BMA balance_sheet (annual, 2021-12-31) — Other Equity Interest: 173290106000.00
BMA income_statement (annual, 2021-12-31) — Other Gand A: 91975649000.00
BMA balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 16370965000.00
BMA cash_flow (annual, 2021-12-31) — Other Non Cash Items: 694655474000.00
BMA income_statement (annual, 2021-12-31) — Other Non Interest Expense: 169725381000.00
BMA income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -402701777000.00
BMA balance_sheet (annual, 2021-12-31) — Other Payable: 128655036000.00
BMA balance_sheet (annual, 2021-12-31) — Other Properties: 95966806000.00
BMA balance_sheet (annual, 2021-12-31) — Other Receivables: 63307524000.00
BMA income_statement (annual, 2021-12-31) — Other Special Charges: 402701777000.00
BMA balance_sheet (annual, 2021-12-31) — Payables: 201060694000.00
BMA balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 201060694000.00
BMA balance_sheet (annual, 2021-12-31) — Prepaid Assets: 2472796000.00
BMA income_statement (annual, 2021-12-31) — Pretax Income: 145943999000.00
BMA cash_flow (annual, 2021-12-31) — Purchase Of Business: -216271000.00
BMA cash_flow (annual, 2021-12-31) — Purchase Of PPE: -41809798000.00
BMA balance_sheet (annual, 2021-12-31) — Receivables: 123402984000.00
BMA income_statement (annual, 2021-12-31) — Reconciled Depreciation: 43224593000.00
BMA income_statement (annual, 2021-12-31) — Rent And Landing Fees: 707770000.00
BMA income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 707770000.00
BMA cash_flow (annual, 2021-12-31) — Repayment Of Debt: -47908004000.00
BMA cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
BMA balance_sheet (annual, 2021-12-31) — Retained Earnings: -85721104000.00
BMA income_statement (annual, 2021-12-31) — Salaries And Wages: 244234357000.00
BMA income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 5293379000.00
BMA income_statement (annual, 2021-12-31) — Selling General And Administration: 350721378000.00
BMA balance_sheet (annual, 2021-12-31) — Share Issued: 647052567.00
BMA income_statement (annual, 2021-12-31) — Special Income Charges: -402701777000.00
BMA balance_sheet (annual, 2021-12-31) — Stockholders Equity: 466723603000.00
BMA balance_sheet (annual, 2021-12-31) — Tangible Book Value: 450352638000.00
BMA income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: -19669617485.00
BMA income_statement (annual, 2021-12-31) — Tax Provision: 7194479000.00
BMA income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.05
BMA cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -67120479000.00
BMA balance_sheet (annual, 2021-12-31) — Total Assets: 1946567225000.00
BMA balance_sheet (annual, 2021-12-31) — Total Capitalization: 554312315000.00
BMA balance_sheet (annual, 2021-12-31) — Total Debt: 90355106000.00
BMA balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 466797391000.00
BMA balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 1479769834000.00
BMA balance_sheet (annual, 2021-12-31) — Total Tax Payable: 20628821000.00
BMA income_statement (annual, 2021-12-31) — Total Unusual Items: -401420765000.00
BMA income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -401420765000.00
BMA income_statement (annual, 2022-12-31) — +Total Revenue: 3280116837000.00
BMA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 186990221000.00
BMA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -130418518000.00
BMA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2636294781000.00
BMA income_statement (annual, 2022-12-31) — Basic Average Shares: 63941300.00
BMA income_statement (annual, 2022-12-31) — Basic EPS: 673.09
BMA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4094064152000.00
BMA cash_flow (annual, 2022-12-31) — Capital Expenditure: -164965355000.00
BMA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 6119963000.00
BMA balance_sheet (annual, 2022-12-31) — Capital Stock: 639413000.00
BMA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 778796544000.00
BMA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 971649168000.00
BMA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -129487826000.00
BMA balance_sheet (annual, 2022-12-31) — Cash Financial: 85987793000.00
BMA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -169389548000.00
BMA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -164991253000.00
BMA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 3510892401000.00
BMA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 67319504000.00
BMA cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 34120549000.00
BMA cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 366520674000.00
BMA cash_flow (annual, 2022-12-31) — Change In Working Capital: 1009662599000.00
BMA cash_flow (annual, 2022-12-31) — Changes In Cash: 3176511600000.00
BMA balance_sheet (annual, 2022-12-31) — Common Stock: 639413000.00
BMA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -129487826000.00
BMA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1594856139000.00
BMA balance_sheet (annual, 2022-12-31) — Construction In Progress: 4037144000.00
BMA cash_flow (annual, 2022-12-31) — Depreciation: 15248627000.00
BMA cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 103405915000.00
BMA income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 103405915000.00
BMA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 103405915000.00
BMA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 103405915000.00
BMA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 103405915000.00
BMA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 7382000.00
BMA income_statement (annual, 2022-12-31) — Diluted Average Shares: 63941300.00
BMA income_statement (annual, 2022-12-31) — Diluted EPS: 673.09
BMA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 276451498000.00
BMA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 856610716000.00
BMA balance_sheet (annual, 2022-12-31) — Employee Benefits: 3503012000.00
BMA cash_flow (annual, 2022-12-31) — End Cash Position: 5085503499000.00
BMA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -169389548000.00
BMA cash_flow (annual, 2022-12-31) — Free Cash Flow: 3345927046000.00
BMA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 306237052000.00
BMA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1264499929000.00
BMA income_statement (annual, 2022-12-31) — General And Administrative Expense: 748334621000.00
BMA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 54308754000.00
BMA balance_sheet (annual, 2022-12-31) — Gross PPE: 447629982000.00
BMA cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1594697224000.00
BMA balance_sheet (annual, 2022-12-31) — Income Tax Payable: 107203884000.00
BMA income_statement (annual, 2022-12-31) — Insurance And Claims: 18728231000.00
BMA income_statement (annual, 2022-12-31) — Interest Expense: 2090993994000.00
BMA income_statement (annual, 2022-12-31) — Interest Income: 4169461568000.00
BMA balance_sheet (annual, 2022-12-31) — Invested Capital: 1827930415000.00
BMA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -164991253000.00
BMA balance_sheet (annual, 2022-12-31) — Investments And Advances: 3069318292000.00
BMA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 33254671000.00
BMA balance_sheet (annual, 2022-12-31) — Leases: 25292305000.00
BMA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 6119963000.00
BMA balance_sheet (annual, 2022-12-31) — Long Term Debt: 233074276000.00
BMA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 239194239000.00
BMA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 33254671000.00
BMA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -66121926000.00
BMA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 3555025000.00
BMA balance_sheet (annual, 2022-12-31) — Long Term Provisions: 8682459000.00
BMA balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 112873598000.00
BMA balance_sheet (annual, 2022-12-31) — Minority Interest: 263735000.00
BMA income_statement (annual, 2022-12-31) — Minority Interests: -48042000.00
BMA cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -573816274000.00
BMA income_statement (annual, 2022-12-31) — Net Income: 276451498000.00
BMA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 276451498000.00
BMA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 276499540000.00
BMA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 276451498000.00
BMA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 276451498000.00
BMA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 401071593000.00
BMA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 276499540000.00
BMA income_statement (annual, 2022-12-31) — Net Interest Income: 2078467574000.00
BMA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -32867255000.00
BMA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -32867255000.00
BMA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -7034467000.00
BMA cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -25898000.00
BMA balance_sheet (annual, 2022-12-31) — Net PPE: 317211464000.00
BMA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -164965355000.00
BMA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1540547385000.00
BMA balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 40903089000.00
BMA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 40903089000.00
BMA balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3503012000.00
BMA income_statement (annual, 2022-12-31) — Normalized Income: 1347396186203.00
BMA income_statement (annual, 2022-12-31) — Occupancy And Equipment: 42291334000.00
BMA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3510892401000.00
BMA cash_flow (annual, 2022-12-31) — Operating Gains Losses: -573816274000.00
BMA income_statement (annual, 2022-12-31) — Operating Revenue: 3280116837000.00
BMA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 647052567.00
BMA cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -3041682969000.00
BMA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1264499929000.00
BMA balance_sheet (annual, 2022-12-31) — Other Equity Interest: 567267912000.00
BMA income_statement (annual, 2022-12-31) — Other Gand A: 188545257000.00
BMA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 54308754000.00
BMA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2542035890000.00
BMA income_statement (annual, 2022-12-31) — Other Non Interest Expense: 408156945000.00
BMA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1551819047000.00
BMA balance_sheet (annual, 2022-12-31) — Other Payable: 400741645000.00
BMA balance_sheet (annual, 2022-12-31) — Other Properties: 305426935000.00
BMA balance_sheet (annual, 2022-12-31) — Other Receivables: 165496503000.00
BMA balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 429468486000.00
BMA income_statement (annual, 2022-12-31) — Other Special Charges: 1555496718000.00
BMA balance_sheet (annual, 2022-12-31) — Payables: 507945529000.00
BMA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 507945529000.00
BMA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 11141418000.00
BMA income_statement (annual, 2022-12-31) — Pretax Income: 401071593000.00
BMA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -164965355000.00
BMA balance_sheet (annual, 2022-12-31) — Receivables: 352486724000.00
BMA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 103405915000.00
BMA income_statement (annual, 2022-12-31) — Rent And Landing Fees: 1176701000.00
BMA income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 1176701000.00